http://www.mynewsdesk.com/us/pressroom/duocort/news/list Mynewsdesk nyhetsfeed direkt från källan http://www.mynewsdesk.com/us/pressroom/duocort/news/list http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png 128 23 sv 15 Tue, 15 Mar 2011 01:30:00 -0400 DuoCorts nya mer fysiologiska behandling för den sällsynta och livshotande sjukdomen binjurebarksvikt, som vanligen kallas Addisons sjukdom, fick nyligen registrerat varumärke godkänt inom EU. Varumärket är PLENADREN. Produkten, som har status som särläkemedel i Europa och USA, är nu i registreringsprocessen för marknadsgodkännande i EU. http://www.mynewsdesk.com/se/pressroom/duocort/news/view/varumaerke-foer-duocorts-nya-behandling-godkaent-i-eu-19002?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/duocort/news/view/varumaerke-foer-duocorts-nya-behandling-godkaent-i-eu-19002?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news ViropPharma Incorporated Tue, 27 Oct 2009 09:25:21 -0400 PULS's Head of Business Development, Maria Forss, is one of the 200 women selected by Maud Olofsson, the Minister for Enterprise and Energy, in collaboration with ALMI Företagspartner, to participate in the Styrelsekraft program. This is a national mentoring program targeting qualified and experienced women who have the ambition to be board members of both private and public companies. http://www.mynewsdesk.com/se/pressroom/duocort/news/view/maria-forss-selected-in-swedish-initiative-for-women-board-members-556?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/duocort/news/view/maria-forss-selected-in-swedish-initiative-for-women-board-members-556?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news ViropPharma Incorporated